PubMed · 7896409
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
M Hiranandani, B R Thapa, I Kaur. 1994. Ketamine.. https://pubmed.ncbi.nlm.nih.gov/7896409/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
The effect of weak electromagnetic stimulation on the emergence of conditioned analgesia was examined in the adult rat. Subjects were conditioned to associate a continuous 20 kHz ultrasonic tone (CS) with 0.2 mA footshock (UCS-) over five successive days. For 30 min either before or after conditioning sessions, rats were exposed to sham or pulsed (primed burst potentiation) magnetic fields (500 nT). At the end of the conditioning phase, all animals were evaluated for anticipatory analgesia following CS presentation using a hotplate analgesiometer. Data analysis suggested a statistically significant attenuation of fear-conditioned analgesia in rats exposed to electromagnetic stimulation prior to conditioning, whereas post-conditioning exposure potentiated the reduction in pain sensitivity compared to baseline measures. The present results suggest that the emergence of fear-conditioned responses is sensitive to whole body exposure to a magnetic field pattern that has been shown to induce long-term potentiation in hippocampal slices.
Synthetic cannabinoids produce behavioral analgesia and suppress pain neurotransmission, raising the possibility that endogenous cannabinoids serve naturally to modulate pain. Here, the development of a sensitive method for measuring cannabinoids by atmospheric pressure-chemical ionization mass spectrometry permitted measurement of the release of the endogenous cannabinoid anandamide in the periaqueductal gray (PAG) by in vivo microdialysis in the rat. Electrical stimulation of the dorsal and lateral PAG produced CB1 cannabinoid receptor-mediated analgesia accompanied by a marked increase in the release of anandamide in the PAG, suggesting that endogenous anandamide mediates the behavioral analgesia. Furthermore, pain triggered by subcutaneous injections of the chemical irritant formalin substantially increased the release of anandamide in the PAG. These findings indicate that the endogenous cannabinoid anandamide plays an important role in a cannabinergic pain-suppression system existing within the dorsal and lateral PAG. The existence of a cannabinergic pain-modulatory system may have relevance for the treatment of pain, particularly in instances where opiates are ineffective.
The aim of this paper is to study the influence of salmon calcitonin (SCT) on opioid analgesia when opioid transduction pathways are functionally uncoupled from Gi/o proteins by treatment with pertussis toxin (PTX). The antinociceptive effect of morphine and three selective opioid agonists, [D-Ala2,N-Me-Phe2,Gly5-ol]enkephalin (DAMGO) (OP(3-mu receptor agonist), [D-Pen2.5]-enkephalin (OP-1-delta receptor agonist) and trans-( +/- )-3,4-dichloro-N-methyl-N-[2-1(-pyrrolidinyl)-cyclohexyl]-benzene-acetam ide methane sulfonate (U-50, 488H) (OP1-kappareceptor agonist) was evaluated, using the tail flick test, in mice treated with PTX or with PTX and SCT. PTX blocked the antinociceptive effect of the opioids, being the antinociception similar in control animals and in mice treated with PTX and SCT. Thus, SCT prevents the effect of the blockade of Gi/o-proteins. From this it could be suggested that calcitonin activates alternative antinociceptive mechanisms that are not dependent on Gi/o-proteins.